PISCES safety study of CTX cells in the treatment of patients with stable ischaemic stroke
Clinical Trial Stage: Phase I
Trial Purpose: To test safety of CTX cells delivered by injection into the damaged brains of male patients > 60 left moderately to severely disabled 6 months to 5 years following an ischaemic stroke
Status : Study completed
Efficacy study of CTX cells in patients with stable paresis of the arm following an ischaemic stroke
Clinical Trial Stage: Phase II
Trial Purpose: To determine if treatment at a dose of 20m cells improves recovery in use of paretic arm in stroke patients to justify a larger pivotal study
Status : Data Reported
Randomised, placebo-controlled study of efficacy and safety of CTX cells in subjects with disability following ischaemic stroke.
Clinical Trial Stage: Phase IIb
Trial Purpose: To assess the efficacy of intracerebral CTX0E03 DP by change in degree of dependency and disability from baseline, as measured by modified Rankin Score (mRS).
Status : First site initiated – patient enrolment commencing shortly.
Open label prospective study of the safety and tolerability of the human retinal progenitor cell (hRPC) therapy candidate in the treatment of patients with retinitis pigmentosa
Clinical Trial Stage: Phase I/IIa
Trial Purpose: To evaluate the safety, tolerability and preliminary efficacy of sub-retinally transplanted hRPCs in patients with advanced retinitis pigmentosa.
Next milestone: Read out in mid-2019
Non-interventional, observational study for patients with stable ischaemic stroke to document clinical course and establish pool of patients for on-going trials
Clinical Trial Stage: Observational
Trial Purpose: To build data set in untreated disabled stroke patients and facilitate on-going clinical trials
Next milestone: Study completed
Ascending dose safety study of CTX cells in patients with lower limb ischaemia
Clinical Trial Stage: Phase I
Trial Purpose: To investigate the safety and tolerability of intramuscular injections of CTX cells in patients with peripheral arterial disease
Next milestone: Study completed
Further information regarding our clinical trials, including relevant contact details, may be found on clinicaltrials.gov, a registry of clinical trials providing patients, family members, and members of the public free and easy access to information on clinical studies for a wide range of diseases and conditions: please click here.
